Altered gene expressions of ghrelin, PYY, and CCK in the gastrointestinal tract of the hyperphagic intrauterine growth restriction rat offspring

Hormone and Metabolic Research

Volumn 43, Issue 3, 2011, Pages 178-182

  Nagata, E ^a,c   Nakagawa, Y ^a   Yamaguchi, R ^a   Fujisawa, Y ^a   Sano, S ^a   Satake, E ^a   Matsushita, R ^a   Nakanishi, T ^a   Liu, Y ^b   Ohzeki, T ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c NONE   (Japan)

Author keywords

anorexigenic gut hormone; maternal food restriction; obesity; orexigenic gut hormone

Indexed keywords

CHOLECYSTOKININ; GHRELIN; PEPTIDE YY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLON; CONTROLLED STUDY; DUODENUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; GASTROINTESTINAL TRACT; GENE EXPRESSION; GESTATIONAL AGE; HYPERPHAGIA; ILEUM; INTRAUTERINE GROWTH RETARDATION; JEJUNUM; MALE; MALNUTRITION; MATERNAL NUTRITION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROGENY; RAT;

ADULT; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CHOLECYSTOKININ; DISEASE MODELS, ANIMAL; EATING; FEMALE; FETAL GROWTH RETARDATION; GASTROINTESTINAL TRACT; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GHRELIN; HUMANS; HYPERPHAGIA; MALE; PEPTIDE YY; RATS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

ANIMALIA; RATTUS;

EID: 79952486615     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1270528     Document Type: Article

References (29)

1. Gluckman PD, Hanson MA. Living with the past: Evolution, development, and patterns of disease. Science 2004 305 1733-1736 (Pubitemid 39249632)
2. Fujisawa Y, Nakagawa Y, Li R, Ohzeki T. Streptozotocin-induced diabetes in the pregnant rat reduces 11 beta-hydroxysteroid dehydrogenase type 2 expression in placenta and fetal kidney. Life Sci 2004 75 2797-2805 (Pubitemid 39349266)
3. Fujisawa Y, Nakagawa Y, Li RS, Liu YJ, Ohzeki T. Diabetic pregnancy in rats leads to impaired glucose metabolism in offspring involving tissue-specific dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 expression. Life Sci 2007 81 724-731 (Pubitemid 47285194)
4. Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 2006 27 141-169
5. Jaquet D, Deghmoun S, Chevenne D, Collin D, Czernichow P, Levy-Marchal C. Dynamic change in adiposity from fetal to postnatal life is involved in the metabolic syndrome associated with reduced fetal growth. Diabetologia 2005 48 849-855 (Pubitemid 40767976)
6. Desai M, Babu J, Ross MG. Programmed metabolic syndrome: prenatal undernutrition and postweaning overnutrition. Am J Physiol Regul Integr Comp Physiol 2007 293 R2306-R2314 (Pubitemid 350224024)
7. Desai M, Gayle D, Babu J, Ross MG. Programmed obesity in intrauterine growth-restricted newborns: modulation by newborn nutrition. Am J Physiol Regul Integr Comp Physiol 2005 288 R91-R96 (Pubitemid 40023917)
8. McMillen IC, Adam CL, Muhlhausler BS. Early origins of obesity: programming the appetite regulatory system. J Physiol 2005 565 9-17 (Pubitemid 40723686)
9. Plagemann A. Perinatal programming and functional teratogenesis: impact on body weight regulation and obesity. Physiol Behav 2005 86 661-668 (Pubitemid 41728984)
10. Ikenasio-Thorpe BA, Breier BH, Vickers MH, Fraser M. Prenatal influences on susceptibility to diet-induced obesity are mediated by altered neuroendocrine gene expression. J Endocrinol 2007 193 31-37 (Pubitemid 46638529)
11. Vincent RP, Ashrafian H, le Roux CW. Mechanisms of disease: the role of gastrointestinal hormones in appetite and obesity. Nat Clin Pract Gastroenterol Hepatol 2008 5 268-277 (Pubitemid 351637912)
12. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999 402 656-660 (Pubitemid 129516334)
13. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature 2001 409 194-198 (Pubitemid 32144284)
14. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985 89 1070-1077 (Pubitemid 16231572)
15. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002 418 650-654
16. Little TJ, Horowitz M, Feinle-Bisset C. Role of cholecystokinin in appetite control and body weight regulation. Obes Rev 2005 6 297-306 (Pubitemid 41578599)
17. Burdge GC, Hanson MA, Slater-Jefferies JL, Lillycrop KA. Epigenetic regulation of transcription: A mechanism for inducing variations in phenotype (fetal programming) by differences in nutrition during early life? Br J Nutr 2007 97 1036-1046 (Pubitemid 46925352)
18. Hayashida T, Nakahara K, Mondal MS, Date Y, Nakazato M, Kojima M, Kangawa K, Murakami N. Ghrelin in neonatal rats: distribution in stomach and its possible role. J Endocrinol 2002 173 239-245 (Pubitemid 34552452)
19. Haqq AM, Farooqi IS, O'Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ. Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 2003 88 174-178 (Pubitemid 36115161)
20. Gomez G, Zhang T, Rajaraman S, Thakore KN, Yanaihara N, Townsend CM Jr, Thompson JC, Greeley GH. Intestinal peptide YY: ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel. Am J Physiol 1995 268 G71-G81
21. Robinson PH, Moran TH, Goldrich M, McHugh PR. Development of cholecystokinin binding sites in rat upper gastrointestinal tract. Am J Physiol 1987 252 G529-G34
22. Brand SJ. The post-natal development of cholecystokinin-like activity in the brain and small intestine of the rat. J Physiol 1982 326 425-433 (Pubitemid 12117291)
23. Nakahara T, Kojima S, Tanaka M, Yasuhara D, Harada T, Sagiyama K, Muranaga T, Nagai N, Nakazato M, Nozoe S, Naruo T, Inui A. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res 2007 41 814-820 (Pubitemid 46693895)
24. Tamai H, Takemura J, Kobayashi N, Matsubayashi S, Matsukura S, Nakagawa T. Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy. Metabolism 1993 42 581-584 (Pubitemid 23141628)
25. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003 349 941-948 (Pubitemid 37064767)
26. Baranowska B, Radzikowska M, Wasilewska-Dziubinska E, Roguski K, Borowiec M. Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity. Diabetes Obes Metab 2000 2 99-103 (Pubitemid 33072164)
27. Huda MS, Wilding JP, Pinkney JH. Gut peptides and the regulation of appetite. Obes Rev 2006 7 163-182
28. Vickers MH, Breier BH, Cutfield WS, Hofman PL, Gluckman PD. Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab 2000 279 E83-E87 (Pubitemid 30609948)
29. Boersma B, Wit JM. Catch-up growth. Endocr Rev 1997 18 646-661 (Pubitemid 27435538)